A Novel Antifolate, MX-68, Inhibits the Development of Autoimmune Disease in MRL/lpr Mice | Citedby Results | International Archives of Allergy and Immunology | Karger Publishers

Skip to Main Content

Skip Nav Destination

A Novel Antifolate, MX-68, Inhibits the Development of Autoimmune Disease in MRL/lpr Mice

Int Arch Allergy Immunol (1997) 113 (4): 454–459.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs

Koichi Nagao
Hirotomo Akabane
Taisei Masuda
Masato Komal
Hiroyuki Tanaka
Hiroichi Nagai

Journal of Pharmacy and Pharmacology (2004) 56 (2): 187.

Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX‐68

M. Carmen Montesinos
Avani Desai
Dave Delano
Jiang‐Fan Chen
J. Stephen Fink
Marlene A. Jacobson
Bruce N. Cronstein

Arthritis & Rheumatism (2003) 48 (1): 240.

Polyglutamation of antifolates is not required for induction of extracellular release of adenosine or expression of their anti-inflammatory effects

Kazumi Urakawa
Masahiko Mihara
Takashi Suzuki
Akinori Kawamura
Ken-ichi Akamatsu
Yasuhisa Takeda
Naoyuki Kamatani

Immunopharmacology (2000) 48 (2): 137.

Nonlinear Disposition Kinetics of a Novel Antifolate, MX-68, in Rats

Yong-Hae Han
Yukio Kato
Yuichi Sugiyama

The Journal of Pharmacology and Experimental Therapeutics (1999) 291 (1): 204.

Binding and transport of methotrexate and its derivative, MX-68, across the brush-border membrane in rat kidney

Yong-Hae Han
Yukio Kato
Yuichi Sugiyama

Biopharmaceutics & Drug Disposition (1999) 20 (8): 361.